Home / Inspections / 625796

FDA Inspection 625796 — Resilience US, Inc.

Resilience US, Inc. — FEI 1000305672

The FDA completed an inspection of Resilience US, Inc. on November 13, 2009 in Allston, MA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
November 13, 2009
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Allston, MA (United States)

Facility

Other inspections at this facility

  • 1102300 (NAI Wed Aug 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1028333 (NAI Thu Sep 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1021959 (VAI Fri Aug 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 897817 (VAI Thu Sep 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 595314 (OAI Thu May 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources